Amneal Pharmaceuticals, Inc. (AMRX)

USD 7.69

(-4.71%)

Inventory Summary of Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.'s latest annual inventory in 2023 was 581.38 Million USD , up 9.54% from previous year.
Amneal Pharmaceuticals, Inc.'s latest quarterly inventory in 2024 Q2 was 575.62 Million USD , up 0.87% from previous quarter.
Amneal Pharmaceuticals, Inc. reported annual inventory of 530.73 Million USD in 2022, up 8.45% from previous year.
Amneal Pharmaceuticals, Inc. reported annual inventory of 489.38 Million USD in 2021, down -0.26% from previous year.
Amneal Pharmaceuticals, Inc. reported quarterly inventory of 570.65 Million USD for 2024 Q1, down -1.85% from previous quarter.
Amneal Pharmaceuticals, Inc. reported quarterly inventory of 576.47 Million USD for 2023 Q3, up 4.71% from previous quarter.

Annual Inventory Chart of Amneal Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Inventory of Amneal Pharmaceuticals, Inc. (2023 - 2015)

Year	Inventory	Inventory Growth
2023	581.38 Million USD	9.54%
2022	530.73 Million USD	8.45%
2021	489.38 Million USD	-0.26%
2020	490.64 Million USD	28.76%
2019	381.06 Million USD	-16.66%
2018	457.21 Million USD	60.97%
2017	284.03 Million USD	6.72%
2016	266.16 Million USD	13.28%
2015	234.96 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	575.62 Million USD	0.87%
2024 Q1	570.65 Million USD	-1.85%
2023 Q3	576.47 Million USD	4.71%
2023 Q2	550.55 Million USD	4.07%
2023 FY	581.38 Million USD	9.54%
2023 Q1	529.04 Million USD	-0.32%
2023 Q4	581.38 Million USD	0.85%
2022 Q4	530.73 Million USD	-2.41%
2022 Q3	543.85 Million USD	2.03%
2022 Q2	533.02 Million USD	4.06%
2022 FY	530.73 Million USD	8.45%
2022 Q1	512.24 Million USD	4.67%
2021 Q4	489.38 Million USD	-5.93%
2021 Q1	497 Million USD	1.3%
2021 Q2	523.38 Million USD	5.31%
2021 FY	489.38 Million USD	-0.26%
2021 Q3	520.24 Million USD	-0.6%
2020 Q3	475.76 Million USD	7.16%
2020 Q1	437.95 Million USD	14.93%
2020 Q4	490.64 Million USD	3.13%
2020 FY	490.64 Million USD	28.76%
2020 Q2	443.95 Million USD	1.37%
2019 Q2	414.62 Million USD	-7.51%
2019 FY	381.06 Million USD	-16.66%
2019 Q4	381.06 Million USD	-5.17%
2019 Q3	401.82 Million USD	-3.09%
2019 Q1	448.29 Million USD	-1.95%
2018 Q4	457.21 Million USD	-6.84%
2018 FY	457.21 Million USD	60.97%
2018 Q3	490.76 Million USD	-4.24%
2018 Q2	512.47 Million USD	56.3%
2018 Q1	327.88 Million USD	15.44%
2017 Q3	277.74 Million USD	0.0%
2017 Q1	- USD	-100.0%
2017 Q4	284.03 Million USD	2.27%
2017 FY	284.03 Million USD	6.72%
2016 FY	266.16 Million USD	13.28%
2016 Q4	266.16 Million USD	0.0%
2015 FY	234.96 Million USD	0.0%

Peer Inventory Comparison of Amneal Pharmaceuticals, Inc.

Name	Inventory	Inventory Difference
Bausch Health Companies Inc.	1.54 Billion USD	62.346%
Catalent, Inc.	574 Million USD	-1.286%
Emergent BioSolutions Inc.	328.9 Million USD	-76.766%
Elanco Animal Health Incorporated	1.73 Billion USD	66.491%
Perrigo Company plc	1.14 Billion USD	49.042%
Teva Pharmaceutical Industries Limited	4.02 Billion USD	85.541%
Zoetis Inc.	2.56 Billion USD	77.325%